Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia.


Clinical Trial Description

The purpose of this study is to use a brain imaging method called PIB PET and VAT PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia. The investigators will be including both PD and normal subjects in this study. This a long term study and we are considering including a total of 320 participants in this protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02763683
Study type Observational
Source Washington University School of Medicine
Contact Kaleigh Oberndorfer, RN, BSN
Phone 314 3620420
Email kaleigh@wustl.edu
Status Recruiting
Phase
Start date June 2016
Completion date March 2030